JUSTPAID, AI-POWERED FINANCE STARTUP, ANNOUNCES NEW FINANCIAL CHATBOT CAPABILITIES
The chatbot will feature custom action tiles and metrics tailored for topics like cash flow, allowing founders and business operators to have more focused conversations. Financial data from sources like QuickBooks and
Part of JustPaid's overarching vision for the chatbot is to integrate with Stripe and other tech-leading money movement vendors, allowing company operators, bookkeepers and accountants to process transactions seamlessly and directly within the chatbot, and thus providing a more straightforward experience for payments and services.
Leveraging new AI technology, the financial chatbot will display interactive components for a richer experience, opening up possibilities to visualize cash flows and other financial data over time in a more engaging format.
"We are committed to creating the best financial experience possible for businesses," says
Chat.justpaid.io aims to provide everything startups need for financial management and conversations in one place through its conversational interface. The new features announced today further this mission by enhancing insights, integration, and interactivity.
"We are aiming to have a super context-relevant focused chat, so that when you log in, the chatbot immediately tells you what is happening in your business with real-time tiles," says
A link to try the financial AI can be found here: chat.justpaid.io.
In addition, the brand has launched a version of this chatbot on Android, with iPhone soon to follow: play.google.com/store/apps/details?id=com.thefireskater.justpaid.
For more on JustPaid, visit: JustPaid.io, and follow along on YouTube and Instagram.
Media Contact: |
View original content to download multimedia:https://www.prnewswire.com/news-releases/justpaid-ai-powered-finance-startup-announces-new-financial-chatbot-capabilities-302081364.html
SOURCE Just Paid
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ericsson reports second quarter results 2026
- Peptide Tracker Launches Founding Member Program, Letting Users Support the App Without a Paywall
- FDA approves Leqembi Iqlik® (lecanemab-irmb) subcutaneous injection as a starting dose for early Alzheimer's disease
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share